# Ben Woodington

> Ben Woodington is the co-founder and CEO of Coherence Neuro, a deep-tech company building SOMA-1, a button-sized, MRI-safe brain-computer interface that listens to and electrically modulates brain tumors from the inside. A Cambridge-trained chemist-turned-engineer who once built smart inhalers and minimally invasive spinal-cord interfaces, Woodington pivoted his neurotechnology to oncology after realizing almost no one was applying neural-interface engineering to cancer. He argues electricity should become the fourth pillar of cancer therapy alongside surgery, drugs, and radiation, and raised a $10M seed in late 2025 to take the work toward first human trials.

- **Role:** Co-Founder & CEO at Coherence Neuro
- **Organizations:** Coherence Neuro, University of Cambridge, Vectura, Philips
- **Nationality:** British
- **Education:** PhD, Bioelectronics & Materials Science (flexible spinal cord and brain interfaces), lab of Prof. George Malliaras, University of Cambridge, MPhil/Master's in Neurotechnology, University of Cambridge
- **Known for:** Co-founded Coherence Neuro, pioneering 'electro-oncology' as a new approach to cancer care, Led development of SOMA-1, an MRI-safe, button-sized implantable brain-computer interface for monitoring and modulating brain tumors, Raised a $10M seed round (Nov 2025) led by Topology Ventures and Artesian, with Blackbird, Possible Ventures, XEIA and others

## Career timeline

- **pre-PhD** — Worked as a chemist-turned-engineer in medical devices; developed smart nebulizers/inhalers at Philips
- **pre-PhD** — Led development of intelligent drug delivery technologies at Vectura
- **2018** — Met co-founder Elise Jenkins at the University of Cambridge while researching neuroengineering and neuro-oncology
- **2022** — Co-founded Coherence Neuro in Cambridge with Elise Jenkins; work on SOMA-1 begins
- **2025** — Coherence emerges publicly; raises $10M seed round (announced November 2025)
- **2027** — First chronic implantations planned

## Achievements

- Co-founded Coherence Neuro, pioneering 'electro-oncology' as a new approach to cancer care
- Led development of SOMA-1, an MRI-safe, button-sized implantable brain-computer interface for monitoring and modulating brain tumors
- Raised a $10M seed round (Nov 2025) led by Topology Ventures and Artesian, with Blackbird, Possible Ventures, XEIA and others
- Earned a Cambridge PhD on flexible spinal-cord and brain interfaces in Prof. George Malliaras's lab
- Co-authored peer-reviewed research on spinal cord bioelectronic interfaces and motor-function restoration
- Earlier built smart nebulizers at Philips and intelligent drug-delivery tech at Vectura

## Latest updates

- **2025-11** — Coherence Neuro closed a $10M seed round to advance SOMA-1 toward first human trials
- **2026-01** — SOMA electroceutical implant profiled in implantable-device industry press as a system to monitor and treat cancer

## Links

- Website: https://coherenceneuro.com
- LinkedIn: http://www.linkedin.com/in/ben-woodington

---

Profile page: https://yespress.io/ben-woodington
Published by YesPress — https://yespress.io
Last updated: 2026-06-25